Who Is Michael Burry and Why Does His Buying Matter
Michael Burry is a physician turned hedge fund manager who founded Scion Capital and later started Scion Asset Management. He gained fame for predicting the U.S. housing bubble before the 2008 financial crisis, a story popularized in his Scion Capital track record. His public filings and stock picks are closely watched because they often reveal contrarian positions in undervalued or misunderstood companies.
Burry’s investment approach focuses on deep fundamental analysis, concentrated bets, and a willingness to take large short positions when he sees mispricing. His buying decisions are therefore treated as signals of potential value or structural change in a sector. Because he files detailed disclosures with regulators, investors can trace exactly what he buys, sells, and holds over time.
What Michael Burry Is Buying Right Now
Recent Michael Burry buying activity has centered on large stakes in technology and healthcare companies, with notable positions in firms like Tesla and other names tied to artificial intelligence and disruption. His filings show he often builds positions gradually and holds them for years, reflecting a long-term conviction rather than short-term trading. The exact stocks in his portfolio can shift quickly as he re-evaluates valuations and macro conditions.
Burry’s recent portfolio moves highlight a preference for companies with strong balance sheets, durable competitive advantages, and the potential to reshape their industries. He has also shown interest in smaller, less-followed names where he believes the market has overlooked long-term value. Each new position is scrutinized by analysts and retail investors alike for clues about where he sees the biggest opportunities.
Key Companies in Michael Burry’s Recent Buys
Technology and AI-Adjacent Names
Among the companies frequently mentioned in Michael Burry buying reports are large-cap tech firms and AI-focused businesses that are transforming data, software, and hardware. His interest in these names often aligns with his view that traditional valuation metrics do not capture the long-term earnings power of dominant platforms. He has publicly discussed his positions in certain tech leaders, noting their role in automation and data dominance.
Healthcare and Biotech Exposure
Burry has also added stakes in healthcare and biotech companies where he sees long-term demand drivers and pricing power. These positions often reflect his focus on industries with high barriers to entry and strong intellectual property protections. His healthcare picks are closely watched for signals about which subsectors he believes can deliver consistent growth despite regulatory and competitive pressures.
How to Track Michael Burry’s Latest Moves
The most reliable way to track Michael Burry buying is through SEC filings, especially Form 13F and Schedule 13D/G disclosures. These documents reveal the exact number of shares, the companies involved, and the dates of transactions, giving investors a transparent view of his portfolio changes. Major financial news outlets and data platforms also summarize his filings quickly after they are released.
Investors can use these disclosures to compare Burry’s current positions with his past holdings and identify new additions or exits. Because his portfolio is relatively concentrated, each new buy or sell can have an outsized impact on the stock’s price and sentiment. Monitoring his activity alongside broader market trends helps contextualize whether his moves are part of a larger sector rotation or a specific conviction trade.